Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics

HRTX POWR Grades

• HRTX scores best on the Growth dimension, with a Growth rank ahead of 75.73% of US stocks.
• HRTX's strongest trending metric is Sentiment; it's been moving up over the last 170 days.
• HRTX ranks lowest in Quality; there it ranks in the 5th percentile.

HRTX Stock Summary

• Heron Therapeutics Inc's stock had its IPO on August 27, 1987, making it an older stock than 91.46% of US equities in our set.
• With a year-over-year growth in debt of 562.05%, Heron Therapeutics Inc's debt growth rate surpasses 97.71% of about US stocks.
• As for revenue growth, note that HRTX's revenue has grown -16.31% over the past 12 months; that beats the revenue growth of just 10.52% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Heron Therapeutics Inc are MNOV, BLI, ADVM, CCXI, and FREQ.
• Visit HRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.herontx.com.

HRTX Valuation Summary

• In comparison to the median Healthcare stock, HRTX's price/earnings ratio is 113.97% lower, now standing at -5.1.
• Over the past 243 months, HRTX's EV/EBIT ratio has gone down 11.1.
• Over the past 243 months, HRTX's EV/EBIT ratio has gone down 11.1.

Below are key valuation metrics over time for HRTX.

HRTX Growth Metrics

The 5 year cash and equivalents growth rate now stands at 51.85%.
• The 4 year cash and equivalents growth rate now stands at 51.85%.
• Its 3 year net income to common stockholders growth rate is now at -71.62%.

HRTX's revenue has moved down $39,479,000 over the prior 15 months.

The table below shows HRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	86.296	-210.65	-228.318
2021-06-30	83.031	-199.538	-234.138
2021-03-31	83.256	-193.823	-228.313
2020-12-31	88.638	-184.82	-227.278
2020-09-30	103.116	-159.243	-222.917
2020-06-30	125.775	-142.66	-198.284

HRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HRTX has a Quality Grade of D, ranking ahead of 9.05% of graded US stocks.
• HRTX's asset turnover comes in at 0.243 -- ranking 181st of 682 Pharmaceutical Products stocks.
• IBIO, COLL, and PTGX are the stocks whose asset turnover ratios are most correlated with HRTX.

The table below shows HRTX's key quality metrics over time.